ArticleBMC endocrine disorders2025
Correlation between thyroid sensitivity indices and bone metabolism in newly diagnosed middle aged and elderly patients with type 2 diabetes mellitus with normal thyroid function.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of impaired sensitivity to thyroid hormone with low bone mineral density and bone mineral content.Frontiers in endocrinology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the association between thyroid hormone sensitivity indices and bone metabolism markers in newly diagnosed middle-aged and elderly type 2 diabetes mellitus (T2DM) patients with normal thyroid function.
methodWe retrospectively analyzed 350 newly diagnosed T2DM patients (≥ 45 years), stratified by bone mineral density into Group A (normal bone density group) and Group B (low bone mass and osteoporosis group). General data and clinical biochemical parameters were collected: free triiodothyronine (FT3), free thyroxine (FT4), thyroid-stimulating hormone (TSH), 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH), osteocalcin (OC), bone-specific alkaline phosphatase (BALP), serum calcium (Ca), serum phosphorus (P), fasting plasma glucose (FPG), glycosylated hemoglobinA1c (HbA1c), total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), serum creatinine (SCr), serum uric acid (SUA), and estimated Glomerular Filtration Rate (eGFR). Thyroid sensitivity indices calculated were: thyrotropin resistance index (TT4RI), TSH index (TSHI), the ratio of FT3/FT4, and the secretory capacity of the thyroid (SPINA-GT). Associations were assessed using multiple linear regression, binary logistic regression, and stratified analysis.
resultsGroup B patients had lower BMI, DBP, FT3, FT3/FT4 ratio, FPG, HbA1c, TG, SCr and SUA and higher age, female proportion, OC and HDL-C (P < 0.05). Spearman Correlation analysis showed that 25(OH)D was positively associated with FT3/FT4 ratio; Ca was positively associated with FT3; and P was associated with TSH, TT4RI and TSHI and negatively associated with SPINA-GT (P < 0.05). Multiple linear regression analysis showed that FT3, FT3/FT4 ratios were positive factors for serum OC, BALP and Ca, and FT4 was an inverse correlation with serum BALP (P < 0.05). Binary Logistic regression analysis showed that the elevated FT3/FT4 ratio was a protective factor for the occurrence of low bone mass and osteoporosis (P < 0.05). Stratified by HbA1c, the effect of FT3/FT4 ratio on low bone mass and osteoporosis showed that the FT3/FT4 ratio was inversely associated with the occurrence of low bone mass and osteoporosis in the HbA1c < 7% group (P < 0.05). Simple effect analysis of the interaction between FT3/FT4 ratio, HbA1c and bone density showed that T2DM patients with HbA1c ≥ 7% had a lower FT3/FT4 ratio and a higher risk of developing low bone mass and osteoporosis compared to those with HbA1c < 7%.
conclusionIn newly diagnosed middle-aged and elderly T2DM patients with normal thyroid function, the peripheral sensitivity to thyroid hormone indix FT3/FT4 ratio was significantly associated with serum OC, BALP, and Ca levels. The lower FT3/FT4 ratio may increase the risk of low bone mass and osteoporosis in newly diagnosed T2DM patients with normal thyroid function, and the reduced index may serve as a tool for early screening and a predictor of low bone mass and osteoporosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.